Dr. Vedula is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5500
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2017 - 2020- Brigham and Women's HospitalResidency, Internal Medicine, 2013 - 2016
Tufts University School of MedicineClass of 2013
Certifications & Licensure
MA State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 14 citationsBCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.Eva J Schaefer, Helen C Wang, Hannah Q Karp, Clifford A Meyer, Paloma Cejas
Blood Cancer Discovery. 2022-03-01 - 18 citationsSingle-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths.Mariela Cortés-López, Paulina Chamely, Allegra G Hawkins, Robert F Stanley, Ariel D Swett
Cell Stem Cell. 2023-09-07 - 6 citationsPhase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.Andrew A Lane, Jacqueline S Garcia, Evangeline G Raulston, Jada L Garzon, Ilene Galinsky
Blood Advances. 2024-02-13
Press Mentions
CRISPR-Powered Breakthrough: New Blood Cancer DiagnosisOctober 11th, 2024- Rapid Blood Cancer Diagnostic Could Speed Decisions and Save LivesOctober 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
